well lets see idiot...........maybe one has 30 billion in debt and one only has 5 billion
one has earnings that will be at a record this year and drug royalty stream that could be sold for billions......geee i don't see a difference!
i see that in the charts today too and decent accumulation volume come back the last two trading days. Deeply oversold and large short interest will lead to a big short squeeze on any positive news out of the company!
PRGO will jump on it this time!
lol........really? They have 1 billion plus in free cash flow and royalty stream from drug that could be sold for multi billions and only 5 billion in debt.......hardly a scam with high debt like VRX!
get lost shortie!
especially in light that the company had a buyout offer in the last 6 months over double from where it is trading now!
look for buyout at RLYP soon. Multiple parties looking at it as its way undervalued.
as seeking Alpha article pointed out company is way undervalued now and ripe for Mylan or others in this rapidly consolidating industry to pounce on PRGO.
that a huge positive to this drug over others currently used and AZ-9, especially with heart and kidney disease
That should start next week again
Mylan will be right back at PRGO doors very quickly with another 20+ billion dollar deal which will likely succeed this time. Mylan need PRGO badly as there are a lot of synergies in combining the two companies and now Head of company went to VRX its ripe for buyout
with Abbott's 28 billion buyout of St Jude, medical/pharma deals are starting to heat up here. PRGO will get interest very soon by Mylan again and possible others now that it is dirt cheap!